- Biopôle Euromédecine - 1682 Rue de la Valsière - 34790 Grabels
PredictCan Biotechnologies is a startup driven by the willingness to advance and to improve precision medicine in oncology. Because cancer is a complex and heterogeneous disease that leads to major public health and economic issues worldwide, we believe that accurate and sensitive solutions are urgently needed to support patients and save lives.
At PredictCan Biotechnologies, we employ our long-lasting expertise in translational research and precision medicine to deliver innovative tools for cancer detection and treatment. We are continually reevaluating and adapting our products to medical inquiries to provide cutting-edge technologies to patients, clinicians, and pharmaceutical industries supporting their combat against cancer.
We envision a future in which our company as a companion of the health system, brings a personalized care solution to each patient increasing their likelihood to be cured.
Dr. Hong Tuan DUONG is a cofounder of PredictCan Biotechnologies. He received his PhD in Pharmacology and Cell Biology from the University of Strasbourg and worked for eighteen years at the University of Basel in Switzerland developing and supervising translational research projects on innate immunity and liver diseases. Lately, he brought his expertise to the INSERM unit at the University of Strasbourg pursuing his efforts in precision oncology.
Dr. Sara CHERRADI is a cofounder of PredictCan Biotechnologies. She received her PhD in Cancer Biology from the University of Montpellier and completed a postdoctoral fellowship at the University of Strasbourg where she developed as a R&D leader solid expertise on patient-derived models for anticancer preclinical drug development and precision medicine.
Salomé Roux is a research engineer working at PredictCan Biotechnologies. After obtaining the engineer degree in applied biology from the Polytech school of Clermont-Ferrand (France), she worked for 4 years at the CNRS_UMR5203 in Montpellier in partnership with the biotech Revvity, where she acquired solid technical expertise in pharmacology, cellular and molecular biology.